dacarbazine and bq 123

dacarbazine has been researched along with bq 123 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, Y; Bernasconi, CC; Juillerat-Jeanneret, L	1

Other Studies

1 other study(ies) available for dacarbazine and bq 123

Article	Year
Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents. Experimental biology and medicine (Maywood, N.J.), 2006, Volume: 231, Issue:6 Topics: Alkylating Agents; Antineoplastic Agents; Apoptosis; Bosentan; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Delivery Systems; Drug Synergism; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Fas Ligand Protein; Genetic Variation; Humans; Melanoma; Membrane Glycoproteins; Oligopeptides; Peptides, Cyclic; Piperidines; Receptor, Endothelin B; RNA, Messenger; Sulfonamides; Tumor Necrosis Factors	2006

Article

Year

Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents.

Experimental biology and medicine (Maywood, N.J.), 2006, Volume: 231, Issue:6

Topics: Alkylating Agents; Antineoplastic Agents; Apoptosis; Bosentan; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Delivery Systems; Drug Synergism; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Fas Ligand Protein; Genetic Variation; Humans; Melanoma; Membrane Glycoproteins; Oligopeptides; Peptides, Cyclic; Piperidines; Receptor, Endothelin B; RNA, Messenger; Sulfonamides; Tumor Necrosis Factors

2006